EN|CN
Create an international first-class Synthetic biology enterprise

Shanxi Shuangyan Health Industry (Group) Co., Ltd. is a group enterprise that integrates research and development, production, commerce, construction, real estate, park operation, investment, and other business modules. The group has two production and manufacturing enterprises, Shanxi Shuangyan Pharmaceutical Co., Ltd. and Shanxi Shuangyan Biotechnology Co., Ltd.

Shuangyan Pharmaceutical is based on its existing series of preparation products, with a focus on developing Ma Jing series of preparations, slow and controlled release series products, etc.

Based on Synthetic biology, Shuangyan Biology focuses on the development of enzyme series products, biological fermentation raw materials, nutrition and health care raw materials, high value-added intermediates and APIs, and becomes a leader in Synthetic biology industry.


More »
Enzyme preparations and intermediates

A comprehensive pharmaceutical enterprise characterized by biological enzyme preparations and relying on intermediates. Based on Synthetic biology, the company accelerates the research of Biotransformation technology and gene metabolism engineering technology, improves the construction, screening, transformation and industrial application system of industrial enzymes and gene engineering strains, and becomes the leader of Synthetic biology industry。

Raw materials and preparations

A modern high-tech enterprise that integrates drug research and development, production, and sales. The company has a complete industrial chain of pharmaceutical intermediates, raw materials, and formulation products。

The company focuses on the integration of raw materials and preparations; Focus on developing high-value, hemp essence series products; Accelerate the development of high-end formulations such as sustained and controlled release products。

R&D and Innovation
Group Market Map

After nearly a decade of experience, Shuangyan's sales performance has grown rapidly year by year, and its current sales have exceeded 1 billion yuan。

Shuangyan Group has actively expanded its global sales network over the years, with products selling well in over 50 countries and regions such as Europe, the United States, the Middle East, Africa, and Southeast Asia. Actively participate in the joint construction of the "the Belt and Road", establish trade relations with many countries along the "the Belt and Road", and constantly expand cooperation channels。

MORE »
  • 2 billion+

    sales volume

  • 50+

    Best selling in countries and regions

Enterprise Chronicles
  • 2004
    Shanxi Xinbaoyuan Pharmaceutical was established

    Professional production of local anesthesia and antitussive raw materials

  • 2013
    Production of bismuth agent

    Introducing the original research "bismuth agent series" raw materials and preparation products and putting them into production, becoming the first domestic enterprise to complete the industrial chain of bismuth preparation products。

  • 2014
    Absorb and merge Spark Pharmaceuticals

    Introducing medication for children, respiratory system, and cardiovascular systems; Enrich existing product lines。

  • 2015
    Biological enzyme pharmaceutical intermediates

    Commercialized production of biological enzyme series production line and pharmaceutical intermediate D p-hydroxy Phenylglycine series production line。

  • 2016
    digestive system

    The introduction of raw materials and preparations of trimebutine maleate has expanded the distribution of digestive system drugs。

  • 2022
    Shanxi Shuangyan Health Industry Group Established

    Shanxi Shuangyan Biotechnology: Operating Biological Enzyme Series

    Production of products, D-p-hydroxy Phenylglycine series intermediates。

    Shanxi Shuangyan Pharmaceutical: engaged in the production of pharmaceutical raw materials and oral solid preparations。

    Shanghai Banglin: front-end research and development of Synthetic biology and high-end preparation development。

  • 2023
    New Shuangyan Biopharmaceutical Industrial Park

    The first phase covers an area of over 500 acres, with a planned investment of 1.5 billion yuan and 17 new workshops to further expand production capacity。

  • 2024
    Shuangyan Biopharmaceutical Industrial Park

    All facilities have reached full operational capacity and achieved optimized production efficiency.

News Media Center

legal provisionsWebsite MapPrivacy

晋ICP备2023015819号-1 Copyright © 2012-2023 Copyright Shanxi Shuangyan Health Industry (Group) Co., Ltd.